INTRAHEPATIC CHOLANGIOCARCINOMA
Clinical trials for INTRAHEPATIC CHOLANGIOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new INTRAHEPATIC CHOLANGIOCARCINOMA trials appear
Sign up with your email to follow new studies for INTRAHEPATIC CHOLANGIOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Targeted attack: new method pumps Immune-Boosting drug directly to liver tumors
Disease control TerminatedThis early-phase study tested a new way to treat advanced liver cancer. It delivered an experimental immune-stimulating drug (SD-101) directly into the liver's main artery, sometimes combined with standard immunotherapy drugs given by IV. The goal was to see if this targeted appr…
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: TriSalus Life Sciences, Inc. • Aim: Disease control
Last updated Apr 04, 2026 08:20 UTC
-
New scan could help doctors better target liver cancer treatments
Knowledge-focused TerminatedThis study tested a special type of scan to see if it could accurately measure how well the liver is working in patients with liver cancer. The goal was to see if tracking liver function before, during, and after standard treatments like radiation or surgery could help doctors pl…
Matched conditions: INTRAHEPATIC CHOLANGIOCARCINOMA
Phase: NA • Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC